Activation and alteration of lysosomes in multiple system atrophy

NeuroReport

Volumn 23, Issue 5, 2012, Pages 270-276

  Makioka, Kouki ^a   Yamazaki, Tsuneo ^a   Takatama, Masamitsu ^b   Nakazato, Yoichi ^a   Okamoto, Koichi ^a  

^a GUNMA UNIVERSITY   (Japan)

^b Geriatric Research Institute   (Japan)

Author keywords

synuclein; Lysosomes; Microglia; Multiple system atrophy

Indexed keywords

ALPHA SYNUCLEIN; CATHEPSIN D; CD68 ANTIGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2;

ADULT; ARTICLE; CELL ACTIVATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYSOSOME; MALE; MICROGLIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SHY DRAGER SYNDROME;

CASE-CONTROL STUDIES; CATHEPSIN D; FEMALE; HEXOSAMINIDASES; HUMANS; IMMUNOHISTOCHEMISTRY; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; LYSOSOMES; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY;

EID: 84859425839     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0b013e3283503e4f     Document Type: Article

References (25)

1. Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci 2003; 4:49-60. (Pubitemid 37271088)
2. Selkoe DJ, Schenk D. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol 2003; 43:545-584. (Pubitemid 37372653)
3. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. a-Synuclein in Lewy bodies. Nature 1997; 388:839-840.
4. Ciechanover A. Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat Rev 2005; 6:79-86. (Pubitemid 40064901)
5. Bellettato CM, Scarpa M. Pathophysiology of neuropathic lysosomal storage disorders. J Inherit Metab Dis 2010; 33:347-362.
6. Bahr BA, Bendiske J. The neuropathogenic contributions of lysosomal dysfunction. J Neurochem 2002; 83:481-489. (Pubitemid 35231802)
7. Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 1989; 94:79-100. (Pubitemid 20019446)
8. Arima K, Ueda K, Sunohara N, Arakawa K, Hirai S, Nakamura M, et al. NACP/a-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglialcytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol 1998; 96:439-444. (Pubitemid 28474750)
9. Bennett MC, Bishop JF, Leng Y, Chock PB, Chase TN, Mouradian MM. Degradation of a-synuclein by proteasome. J Biol Chem 1999; 274:33855-33858.
10. Mak SK, McCormack AL, Manning-Bog AB, Cuervo AM, Di Monte DA. Lysosomal degradation of alpha-synuclein in vivo. J Biol Chem 2010; 285:13621-13629.
11. Xilouri M, Vogiatzi T, Vekrellis K, Stefanis L. a-Synuclein degradation by autophagic pathways: a potential key to Parkinson's disease pathogenesis. Autophagy 2008; 4:917-919.
12. Chu Y, Dodiya H, Aebischer P, Olanow CW, Kordower JH. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to a-synuclein inclusions. Neurobiol Dis 2009; 3:385-398.
13. Jellinger KA, Lantos PL. Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update. Acta Neuropathol 2010; 119:657-667.
14. Funk KE, Mrak RE, Kuret J. Granulovacuolar degeneration (GVD) bodies of Alzheimer's disease (AD) resemble late-stage autophagic organelles. Neuropathol Appl Neurobiol 2011; 37:295-306.
15. Higashi S, Moore DJ, Yamamoto R, Minegishi M, Sato K, Togo T, et al. Abnormal localization of leucine-rich repeat kinase 2 to the endosomal- lysosomal compartment in Lewy body disease. J Neuropathol Exp Neurol 2009; 68:994-1005.
16. Higashi S, Moore DJ, Minegishi M, Kasanuki K, Fujishiro H, Kabuta T, et al. Localization of MAP1-LC3 in vulnerable neurons and Lewy bodies in brains of patients with dementia with Lewy bodies. J Neuropathol Exp Neurol 2011; 70:264-280.
17. Cataldo AM, Paskevich PA, Kominami E, Nixon RA. Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. Proc Natl Acad Sci USA 1991; 88:10998-11002. (Pubitemid 21915966)
18. Kadokura A, Yamazaki T, Kakuda S, Makioka K, Lemere CA, Fujita Y, et al. Phosphorylation-dependent TDP-43 antibody detects intraneuronal dot-like structures showing morphological characters of granulovacuolar degeneration. Neurosci Lett 2009; 463:87-92.
19. Oh D, Prayson RA. Evaluation of epithelial and keratin markers in glioblastoma multiforme: an immunohistochemical study. Arch Pathol Lab Med 1999; 123:917-920. (Pubitemid 29480451)
20. Ishizawa K, Komori T, Sasaki S, Arai N, Mizutani T, Hirose T. Microglial activation parallels system degeneration in multiple system atrophy. J Neuropathol Exp Neurol 2004; 63:43-52. (Pubitemid 38030232)
21. Stefanova N, Reindl M, Neumann M, Kahle PJ, Poewe W, Wenning GK. Microglial activation mediates neurodegeneration related to oligodendroglial a-synucleinopathy: implications for multiple system atrophy. Mov Disord 2007; 22:2196-2203.
22. Boya P, Kroemer G. Lysosomal membrane permeabilization in cell death. Oncogene 2008; 27:6434-6451.
23. Zhang L, Sheng R, Qin Z. The lysosome and neurodegenerative diseases. Acta Biochim Biophys Sin 2009; 41:437-445.
24. Nixon RA, Cataldo AM, Paskevich PA, Hamilton DJ, Wheelock TR, Kanaley-Andrews L. The lysosomal system in neurons. Involvement at multiple stages of Alzheimer's disease pathogenesis. Ann NY Acad Sci 1992; 674:65-88. (Pubitemid 23077397)
25. Stefanis L, Larsen KE, Rideout HJ, Sulzer D, Greene LA. Expression of A53T mutant but not wild-type a-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J Neurosci 2001; 21:9549-9560. (Pubitemid 34184043)